Polymorphically duplicated genes: Their relevance to phenotypic variation in humans

Annals of Medicine

Volumn 35, Issue 5, 2003, Pages 308-315

  Buckland, Paul R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Gene dosage; Gene duplication; Genomic disorder

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 2A1; CYTOCHROME P450 2D6; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN HEAVY CHAIN; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

CYTOGENETICS; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DOWN SYNDROME; DRUG METABOLISM; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOGENE; SCHIZOPHRENIA; SEQUENCE HOMOLOGY; SHORT SURVEY; SPINAL MUSCULAR ATROPHY;

CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOCHROME P-450 CYP2D6; GENE DELETION; GENES, DUPLICATE; HUMANS; MUSCULAR ATROPHY, SPINAL; NERVE TISSUE PROTEINS; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RNA-BINDING PROTEINS;

EID: 0041386350     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310001276     Document Type: Short Survey

References (48)

1. Eichler EE. Segmental Duplications: What's missing, misas-signed, and misassembled and should we care? Genet Res 2001a; 11: 653-6.
2. Eichler EE. Recent duplication, domain accretion and the dynamic mutation of the human genome. Trends Genet 2001b; 17: 661-9.
3. Bailey JA, Gu Z, Clark RA, Reinert K, Samonte RV, Schwartz S, et al. Recent Segmental Duplications in the Human Genome. Science 2002; 297: 1003-7.
4. The BAC Resource Consortium. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature 2002; 409: 953-8.
5. Mazzarella R, Schlessinger D. Pathological consequences of Sequence duplications in the human genome. Genome Res 1998; 8: 1007-21.
6. Ji Y, Eichler EE, Schwartz S, Nicholls RD. Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 2000; 10: 597-610.
7. Emanuel BS, Shaikh TH. Segmental duplications: An 'expanding' role in genomic instability and disease. Nat Rev Genet 2001; 2: 791-800.
8. Stankiewicz P, Lupski J R. Genome architecture, rearrangements and genomic disorders. Trends Genet 2002; 18: 74-82.
9. Strachen T, Read AP. Human Molecular Genetics. Oxford: BIOS Scientific; 1999.
10. Buckland PR, Hoogendorn B, Guy C, Smith SK, Coleman SL, O'Donovan MC. Experimental evidence for frequent polymorphic gene duplication in the human genome. Am J Hum Genet 2002; 71 suppl: 176.
11. Smith SK, Hoogendoorn B, Guy CA, Coleman SL, O'Donovan MC, Buckland PR. Lack of functional promoter polymorphisms in genes involved in glutamate neurotransmission. Psychiatr Genet. In press.
12. Martín-Santos R, Bulbena A, Porta M, Gago J, Molina L, Duró JC. Association between joint hypermobility syndrome and panic disorder. Am J Psychiatry 1998; 155: 1578-83.
13. Gratacòs M, Nadal M, Martin-Santos R, Pujana MA, Gago J, Peral B, et al. A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 2001; 106: 367-79.
14. McLellan RA, Oscarson M, Seidegård J, Evans DA, Ingelman-Sundberg M. Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics 1997; 7: 187-91.
15. Mitsunaga Y, Kubota T, Ishiguro A, Yamada Y, Sasaki H, Chiba K, et al. Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population. Mutat Res 2002; 505: 83-5.
16. Dalen P, Dahl ML, Ruiz ML, Nordin J, Bertilsson L. 10-hydroxylation of nortryptyline in white persons with 0, 1, 2, 3 and 13 functional CYP2D6 genes. Clin Pharmacol Ther 1998; 63: 444-52.
17. Koppens PJ, Hoogenboezem T, Degenhart HJ. Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Gen 2002; 111: 405-10.
18. Rao Y, Hoffmann E, Zia M, Bodin L, Zeman M, Sellers EM, et al. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking. Mol Pharmacol 2000; 58: 747-55.
19. Xu C, Rao YS, Xu B, Hoffmann E, Jones J, Sellers EM, et al. An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles. Biochem Biophys Res Commun 2002; 290: 318-24.
20. McLellan RA, Oscarson M, Alexandrie AK, Seidegard J, Evans DA, Rannug A, et al. Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTM1 gene that causes ultrarapid enzyme activity. Mol Pharmacol 1997: 958-65.
21. Feldkötter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002; 70: 358-68.
22. Schwartz M, Sørensen N, Hansen FJ, Hertz JM, Nørby S, Tranebjærg L, et al. Quantification, by solid-phase minisequencing, of the telomeric and centromeric copies of the survival motor neuron gene in families with spinal muscular atrophy. Hum Mol Genet 1997; 6: 99-104.
23. Rabbani H, Pan Q, Kondo N, Smith CI, Hammarström L. Duplications and deletions of the human IGHC locus: evolutionary implications. Immunogenetics 1996; 45: 136-41.
24. Bottaro A, Galliana R, Brusco A, Cariota U, Boccazzi C, Barilaro MR, et al. Familial clustering of IGHC deletions and duplications: functional and molecular analysis. Immunogenetics 1993; 37: 356-63.
25. Pan Q, Petit-Frere C, Dai S, Huang P, Morton HC, Brandtzaeg P, et al. Regulation of switching and production of IgA in human B cells in donors with duplicated alphal genes. Eur J Immunol 2001; 31: 3622-30.
26. Franchina M, Kay PH. Allele-specific variation in the gene copy number of human cytosine 5-methyltransferase. Hum Hered 2000; 50: 112-7.
27. Franchina M, Kay PH. DNMT1 gene copy number does not influence susceptibility to development of malignant lympho-proliferative disease. Anticancer Res 2002; 22: 3405-7.
28. H3 gene. J Clin Invest 1995; 96: 1591-600.
29. Townson JR, Barcellos LF, Nibbs RJ. Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol 2002; 32: 3016-26.
30. Tsai C-H, Graw SL, McGavran L. 8p23 duplication reconsidered: is it a true euchromatic variant with no clinical manifestations? J Med Genet 2002; 39: 769-74.
31. Trask BJ, Friedman C, Martin-Gallardo A, Rowen L, Akinbami C, Blankenship J, et al. Members of the olfactory receptor gene family are contained in large blocks of DNA duplicated polymorphically near the ends of human chromosomes. Hum Mol Genet 1998; 7: 13-26.
32. Linardopoulou E, Mefford HC, Nguyen O, Friedman C, van den Engh G, Farwel DG, et al. Transcriptional activity of multiple copies of a subtelomerically located olfactory receptor gene that is polymorphic in number and location. Hum Mol Genet 2001; 10: 2373-83.
33. Fantes JA, Mewborn SK, Lese CM, Hedrick J, Brown RL, Dyomin V, et al. Organisation of the pericentromeric region of chromosome 15: at least four partial gene copies are amplified in patients with a proximal duplication of 15q. J Med Genet 2002; 39: 170-7.
34. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 1997; 94: 587-92.
35. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 1998; 52: 173-85.
36. Riley B, Williamson M, Collier D, Wilkie H, Makoff A. A 3-Mb Map of a Large Segmental Duplication Overlapping the 7-Nicotinic Acetylcholine Receptor Gene (CHRNA7) at Human 15q13-q14. Genomics 2002; 79: 197-209.
37. Borgato L, Bonizzato A, Lunardi C, Dusi S, Andrioli G, Scarperi A, et al. A 1.1-kb duplication in the p67-phox gene causes chronic granulomatous disease. Hum Genet 2001; 108: 504-10.
38. - Polymorphism in the Human Igλ Locus. J Immunol 2002; 169: 271-6.
39. Flint J. Psychiatric genetics: A frightful chromosome. Curr Biol 2001; 11: R907-9.
40. Bergmann TK, Bathum L, Brosen K. Duplication of CYP2D6 predicts high clearance of desipramine but high clearance does not predict duplication of CYP2D6. Eur J Clin Pharmacol 2001; 57: 123-7.
41. Kawanishi C, Furuno T, Kishida I, Matsumura T, Kosaka K. A patient with treatment-resistant schizophrenia and cytochrome P4502D6 gene duplication. Clin Genet 2002; 61: 152-54.
42. Agúndez JA, Gallardo L, Ledesma MC, Lozano L, Rodriguez-Lescure A, Pontes JC, et al. Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients. Oncology 2001; 61: 59-63.
43. Hoogendoorn B, Coleman S, Guy C, Smith K, Buckland PR, Bowen T, et al. Functional Analysis of Human Promoter Polymorphisms. Hum Mol Genet 2003: In press.
44. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW. Allelic Variation in Human Gene Expression. Science 2002; 297: 1143.
45. Harrison P, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003; 361: 417-19.
46. Shapiro BL. The Down syndrome critical region. J. Neural Transm Suppl 1999; 57: 41-60.
47. Pritchard MA, Kola I. The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndrome. J Neural Transm Suppl 1999; 57: 293-303.
48. Reeves RH, Baxter LL, Richtsmeier JT. Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet 2001; 17: 83-8.